Wave Life Sciences announced that the company has been added to the small-cap Russell 2000 and broad-market all-cap Russell 3000 Indexes as part of the annual reconstitution, effective after the U.S. market opens today, June 26, 2023.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on WVE:
- Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes
- Wave Life Sciences Notches Higher despite Drug Trial Setback
- Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
- Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting
- Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update